• Fan Pass launched in July 2020 as a means of bringing a “virtual stage” to fans and giving artists access to the revenue they need, and has since seen remarkable growth
• Platform reports higher numbers in artist signups, live events and performances and social media engagement every month
• April’s Artist Contest is incentivizing new artist streaming, offering $25 to the first 25 artists to schedule their first stream

March 2021 was another record month of growth for mobile technology and marketing company Friendable’s (OTC: FDBL) Fan Pass platform, with an 81% increase in artist sign-ups over February, tallying 575 new artist sign-ups versus 317, respectively. Additionally, the live events and performances streamed by the platform doubled, expressing triple-digit percentage growth (https://ibn.fm/yHZB5). Social media reach and engagement also increased across the board, with impressions up by 19% and Live Channels rising to 69%. Facebook reach rose to 120%, with engagement up 19%. Instagram followers, reach, and interactions also showed a double-digit percentage increase. Friendable’s Fan Pass platform launched in July 2020 at the height of the COVID-19 pandemic, providing an online live streaming concert venue for artists and their fans as an alternative to in-person events. “The COVID-19 pandemic has changed the way we communicate at all levels. Especially the virtual stage, which has demonstrated how effective and far-reaching it can be,” Friendable CEO Robert Rositano, Jr. said. Rositano added that Fan Pass believes this format of engagement is here to stay and will grow into the foreseeable future. “It provides a way for artists at all stages and even local talent to reach audiences far beyond what they could in the past. Fan Pass is well-positioned to assist in the growth of each artist and, in many cases, lead the way to their discovery by millions of fans around the world,” he explained. Artists on the platform earn revenue from fans’ purchases, including subscriptions, merchandise, tickets for exclusive virtual events, and generally from all of the content views or impressions on their channel. Fan Pass allows artists to track their content views and sales through their dashboard, showing real-time payout and earnings information. As an added incentive, monthly contests are also organized with prizes or cash rewards for the artists with the greatest number of live event views. The April Artist Contest is already well underway, with artists already filling up the events calendar – including new artists introducing themselves to the online network. Prizes for the month have changed from those offered in previous months:

• First Place: Streaming Kit ($450 value) or $350 cash
• Second Place: Merch Collection ($300 value) or $200 cash
• Third Place: Custom Design ($100 value) or $50 cash

As a bonus to new artists, the first 25 to schedule, promote, and complete their first stream on Fan Pass will win a $25 prize. Fans who want to subscribe to the platform to watch their favorite artists or discover new ones can subscribe to Fan Pass’s “Virtual Stage” for $3.99 a month or an annual rate of $38.20, saving 20% over paying monthly. A VIP All-Access subscription is available, providing fans with additional content and features, including live performances and online concerts, backstage artist access, livestreamed studio sessions, exclusive behind-the-scenes footage of music video or photoshoots, special interviews with artists, and streams that highlight an artist’s daily life. The rapid growth of Fan Pass indicates this model is a successful approach to supporting artists and fans in maintaining engagement in an industry heavily affected by the ongoing pandemic, positioning Friendable in a leading role in the livestreaming industry. Even with venues potentially reopening to artists and fans, the livestreaming industry is expected to remain strong. Fan Pass is leveraging this expectation, offering a platform with exclusive content and pay-per-view concerts that are more affordable than in-person events, all while creating an ecosystem that embraces all kinds of fans, catering to the diehard fans and followers to create lasting connections. The app is available on both Android and Apple stores. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• The Emaginos model does not set out to replace public education with charter schools; instead, it uses a charter to determine the best ways to implement the model among other schools within the public district
• Emaginos is tackling an exponentially large market, with 98,328 K-12 schools across the nation
• Emaginos’ program elements touch base on several different public school system areas, including curriculum, teachers, calendar and more
• The model presents an ongoing revenue structure; districts pay for the Emaginos model and then have an annual subscription cost
• Implementation of the model within the school incurs minimal costs for Emaginos, allowing for revenue gain from the recurring subscriptions
• The company’s management team has over 50 years of combined experience in education, including the public K-12 school system

Emaginos Inc. is working to improve the education system of the United States through a commitment to integrated, proven best practices. Opposed to replacing public schools with charter schools, Emaginos believes in restoring neighborhood schools and having them serve as focal points of their communities. Through the company’s model, one school in a district is transformed into a charter. This allows the district to write a separate contract for the teachers in the pilot school. The pilot school incorporates the new model into the community and proves the concept. The lessons learned from this charter are then used to transition the model to the other public schools, adapting them to the model while remaining public. To achieve this transformation, Emaginos provides the schools with a wealth of resources ranging from technology infrastructure to curriculum training. The schools transformed by the model operate with economic efficiencies squarely in mind, resulting in a better educational experience for the same or lower overall cost. The company is a REG-A+ Tier 2 public company raising capital for future development and deployment of its transformational public-school model, with the goal of changing the way public schools approach learning. Emaginos was founded in 2008. Program Elements The Emaginos program provides various elements aimed at making the model successful, including:

• Learning Environment:Integrated and proven best practices, multi-level classrooms, diverse small group settings, magnet programs, etc.
• Curriculum:Education customized for individuals, no textbooks, observational assessment rubrics, no more teaching to the test, STEM integration, etc.
• School Calendar:Longer school day, longer school year, internships, college courses, etc.
• Staffing:Teacher mentoring, highly qualified teachers, teacher pay, union support, etc.
• Technology:Technology integration, videoconferencing and telepresence, administrative software, student technical support, etc.
• Wellness and Primary Health Care:Telemedicine, primary health care, wellness simulations, etc.
• Scalable and Transformational:Operates within existing budgets, accountability, research center, national leadership, etc.
• Additional Benefits:Grassroots, unanimity planning, dropout prevention, attendance, etc.

Emaginos Investment Model Emaginos is focused on changing the way that public school transformation is approached. While many in the industry are in favor of the transition to charters or homeschooling, the company believes in keeping the same buildings and teachers while implementing new proven best practices within the existing budget. Some key figures relating to the public school system include:

• There are 98,328 public K-12 schools.
• Total public-school enrollment exceeds 50 million.
• The public school system employs more than 3.1 million teachers.
• Total funding of public education amounts to roughly $597.5 billion, with federal funding accounting for 12.7%, state funding accounting for 43.5% and local funding accounting for 43.8% of the total.

The Emaginos model is not a one-time product sale; it is a subscription service that provides the necessary resources for the public school to transition from traditional “teaching and testing” models to the “learning and doing” model. The Cost of the Emaginos Model Emaginos’ start-up costs are significant as it builds the EdManage platform and its student centered, multidisciplinary, textbook-free, learning-team, project-based curriculum. However, after the platform and curriculum are built, the company expects to incur relatively small incremental costs to sell, deliver and support the program. Even though districts are required to pay for the model and annual subscription, overall, they are expected to come out even or on top in terms of expenditure. With no more textbooks and no need for additional technology, schools can go without extra support staffing, allowing for additional cost savings. Management Team Dr. Keith Larick is the man who developed the Emaginos plan. As a superintendent within the Tracy Unified School District (“TUSD”) 20 years ago, Dr. Larick chose three educators with whom to work, with the goal of changing education. He challenged these educators to take a clean slate approach to design the optimal K-12 education program. Using proven student-centered and organizational best practices, the result was the creation of three charter schools proving the new K-12 model. Allan Jones is the President of Emaginos Inc. He has spent over 40 years working in and around education. He was a classroom teacher, district chief information and technology officer in the public school system, and taught college courses for teachers. Mr. Jones also served as a school board member. He co-founded an online high school, consulting with school districts on technology planning, and worked for Digital Equipment Corporation’s corporate research division. While there, he created programs to identify and transfer ideas from leading universities into the company. After all those years of seeing the good, bad, and ugly within the American public school system, he joined Dr. Larick to transform America’s schools into centers of discovery and innovation. The late Jack Taub was the Chief Visionary of Emaginos Inc. He was from Brooklyn, New York, and dropped out of school to pursue a passion for stamp collecting. He and his brother Bert, both respected philatelists, developed a successful stamp selling business. At one time, they even had an exclusive contract with the USPS, selling their stamp-collecting materials across the country. From those earnings, the brothers invested in what would be considered one of the first social networking applications – though the term didn’t exist yet. Neither brother had a good experience within the K-12 school system, so they turned their sights on fixing it. They teamed up with Dr. Larick to design new models for education adhering to the idea that all students can succeed in education. For more information, visit the company’s website at www.Emaginos.com. NOTE TO INVESTORS: The latest news and updates relating to Emaginos are available in the company’s newsroom at https://ibn.fm/Emaginos

• PULL signs Letter of Intent with Psyence Group to co-develop extraction techniques for production of psilocybin drug formulations
• Psyence is one of world’s first psychedelic mushroom companies operating a federally legal commercial cultivation and extraction facility
• PULL operates best-in-class processing infrastructure under Standard Processing License by Health Canada
• Near term milestones include Canada-based human clinical trials

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently signed a Letter of Intent with the Psyence Group to develop premium extraction techniques for the production of advanced psilocybin formulations that treat the mental health consequences of psychological trauma.

“We are excited about working with the deeply qualified science team at Psyence, one of only a handful of companies in the world operating a vertically integrated, federally licensed psychedelic mushroom facility,” said Pure Extracts CEO Ben Nikolaevsky (https://ibn.fm/iWj6b).

Led by an experienced team of global doctors and scientists, Psyence is one of the world’s first psychedelic mushroom companies operating a federally legal commercial cultivation and extraction facility. The facility, located in Lesotho in Southern Africa, is dedicated to conducting cutting-edge research in neurology, palliative care, neuroscience and drug development. With its solid Canadian network of psychedelic mushroom research and development experts, Pure Extracts plans to leverage Psyence’s network in South Africa, Lesotho and Jamaica to rapidly develop natural psychedelics and novel drug delivery systems for patients across the world.

The companies plan to utilize their combined infrastructure and networks to attain near-term milestones. Pure Extracts operates a best-in-class production and processing facility under a Standard Processing License issued by Health Canada under the Cannabis Act, and the Psyence team has experience in structuring and running clinical trials. As part of their joint venture, both companies aim to conduct Canada-based human clinical trials as part of their near-term milestones.

“This partnership with Pure Extracts will facilitate the importation of our standardized psychedelic mushrooms into Canada, giving us the opportunity to further optimize extraction methods and produce advanced products needed for safe clinical research,” said Psyence Chief Scientific Officer Dr. Justin Grant. “Our companies share the vision of providing the highest quality and most innovative psilocybin products for Canada, as evidenced by our facilities being constructed to GMP standards, and our commitment to rigorous scientific and clinical research for the development of transformational treatments for mental health disorders, with a particular focus on oncology palliative care.”

Pure Extract’s state-of-the-art newly constructed processing facility is built to EU GMP standards with the aim of producing products for worldwide export where their sale and consumption are permitted. As new research reveals the effects of functional and medicinal psychedelic products (https://ibn.fm/pAkIw), Pure Extracts continues to make strides towards establishing a prominent position in the industry through its commitment to developing superior extracts for the rapidly growing plant-based wellness sector.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

 

• License essential to company’s plans to launch in one of world’s largest direct-selling markets
• SHRG honored to expand the Happy Co. into the country of South Korea
• Expansion into South Korea marks significant start to global expansion plans, sets the stage for growth in both U.S. and Asia

Sharing Services Global (OTCQB: SHRG) has obtained a direct-selling license in South Korea (https://ibn.fm/4AJvq); the license represents a key piece of the company’s plans to launch in that country, the third-largest, direct-selling market in the world. “We will be announcing additional products and services as this launch is planned in the near future, but for now, we are very pleased to share this exciting news,” said SHRG CEO John “JT” Thatch. Sharing Services’ strategic Asia Expansion Plan comes at an ideal time for the company, as SHRG just unveiled a new brand identity as the Happy Co. earlier this year. The rebranding features a look and design meant to help its partners and customers “recall happiness and reflect on the importance of family and community in their lives” (https://ibn.fm/zi3ic). Every element of the new brand identity has been deliberately chosen to create, strengthen and maintain the pleasant feelings that already represent the company through its unique blend of proprietary products. “The Happy Co. is not just a name; it is the best descriptor of our mission,” said Bo Short, CEO of SHRG subsidiaries Elevacity Holdings LLC and Elevacity International Holdings LLC. “It directly mirrors our values and purpose of sharing happiness through products and experiences that elevate lives. Our brand partners and our customers live this experience every day. This new branding is an important step as we begin our global expansion in 2021. It connects perfectly to our enhanced business platform and ever-growing ecosystem of products.” “We are honored to have the opportunity to expand the Happy Co. into the country of South Korea,” Short continued. “We are excited for our global family of brand partners and their ability to connect our business platform to entrepreneurs and customers in the great country of South Korea.” The expansion into South Korea “marks a significant start to our global expansion plans and will set the stage for growth both in the U.S. and in Asia simultaneously,” stated SHRG director Fai Chan. “We are glad to have a local Korean team that has tremendous experience both in South Korea and in the direct selling space to head up our expansion efforts in guiding the company to achieve greatness and success in the right way.” More details about the company’s plans to launch in South Korea will be forthcoming, as SHRG prepares pre-launch activities in the coming weeks. Sharing Services Global Corporation, formerly Sharing Services Inc., is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling sector and other industries. The Sharing Services combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com and www.TheHappyCo.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner
• XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards
• The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April
• XPhyto has just completed a rebranding effort that includes the launch of a new website
• The company expects to begin launching other bacteria and virus diagnostic products later this year

With confidence in the world’s mounting recovery from the COVID-19 pandemic growing this year, bioscience industry holding company XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is stepping up its efforts to produce and ultimately commercialize next-generation diagnostic products and new active pharmaceutical ingredients, particularly in regard to the pandemic response. XPhyto has placed its first order for the company’s Covid-ID Lab product from its exclusive diagnostic development partner, Germany’s 3a-diagnostics GmbH, as announced in a Feb. 24 news release (https://ibn.fm/uBX94). The Covid-ID Lab is a rapid, point-of-care RT-PCR test system for COVID that the company expects to be useful for industry partners and licensees, as well as their respective government regulators, in safeguarding against the spread of the highly infectious and potentially fatal virus. The first product order from 3a was for 9,600 tests, which are packaged in 200 kits of 48 tests each, according to the company. Delivery is expected this month and XPhyto anticipates they will then undergo evaluation by the company’s partners and the appropriate government agencies for expected commencement of sales in Q2 2021. “We are pleased to report that all steps towards the launch of Covid-ID Lab remain on track within an ambitious timeline,” XPhyto CEO and Director Hugh Rogers stated in the news release. “Our experienced market launch team is working quickly to bring the product to market, as well as to establish licensing and distribution partnerships. We are confident that Covid-ID Lab, as a 25-minute PCR test with minimal technical and personnel requirements, will be a stand-out product in the COVID-19 test market.” In March, XPhyto received two critical regulatory approvals in Europe to open the door for sales of its rapid, point-of-care COVID testing solution. On March 10, the company announced approval for commercial production under internationally agreed-on ISO 13485 quality standards (https://ibn.fm/qZCXm). On March 18, the company further announced Covid-ID Lab’s approval for in vitro diagnostic device (CE-IVD) use (https://ibn.fm/PqsZI). On March 4, XPhyto announced completion of a corporate rebranding initiative that includes the launch of a new website. “The company is excited to introduce a fresh look at such a pivotal point in our business growth,” Rogers added (https://ibn.fm/A4hzB). XPhyto is on track to launch sales and distribution in Europe in April, and the company is also in talks with potential distribution and wholesale partners in the Middle East. XPhyto intends to continue its rapid, point-of-care product development to target other pandemic-potential illnesses, such as H1N1 (swine flu) and H5N1 (avian flu), as well as a variety of other bacterial and viral infectious diseases. New products under an expanding portfolio could be launched before the end of the year. XPhyto’s research and development operations are located in North America and Europe, but the company’s focus is the European market during these initial stages of product placement. For more information on XPhyto Therapeutics, visit the company’s newly designed website at www.XPhyto.com. NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF

• Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts
• Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care
• With explosion of telemedicine services and increased integration of advanced practice providers, neurologists’ shortage may improve

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge technologies. By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool.

Between 2001 and 2016, the American Academy of Neurology (“AAN”) reported that out-of-pocket costs shot up substantially for privately insured patients. In addition, the distribution of neurologists across the U.S. is uneven, with patients in rural areas less likely to receive care (https://ibn.fm/9sUYR). There are 20 states, according to the 2017 Alzheimer’s Association International Conference, classified as neurology deserts (https://ibn.fm/cGx2k). This term designates an area that has projected a chronic shortage of neurologists alongside a rise in dementia cases.

“In many places, people do not have easy access to specialists, for a variety of reasons. But you may not need a neurologist in every case,” said Beth Kallmyer, MSW, vice president of Constituent Services at the Alzheimer’s Association. “With the right training and tools, primary care physicians can effectively diagnose and treat Alzheimer’s disease. The Alzheimer’s Association is working to arm primary care physicians with the tools they need to manage an increased caseload, as well as care planning guidance.”

Brain Scientific has developed tools that provide primary care physicians in neurology deserts the ability to serve their patients and create specialized treatment plans that provide access to neurologists. Portable, clinical-grade, easy-to-use diagnostic devices are now in place to allow to run EEG tests withing a few minutes. The company is actively working on a secure, cloud-based and highly scalable infrastructure to transmit patient data between neurologists and patients as well as creating artificial intelligence assisted diagnostic analysis.

Currently, across the United States, there is significant disparity between who has access to neurology care and who does not. A MedPate Today article reported that the lowest density had a mean of 9.7 neurologists for every 100,000 Medicare beneficiaries while the highest had 43.1 neurologists for every 100,000 (https://ibn.fm/dGCud). While the number of conditions remained similar, the access to care did not. With the explosion of telemedicine services and an increased integration of advanced practice providers, neurologists’ shortage may just improve.

Through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers, Brain Scientific will create resources to narrow this wide gap. The company’s commercialized products were designed to disrupt the slow, expensive and cumbersome EEG market with easy-to-use, economical and disposable solutions. These devices are so easy to use that any medical professional can use them within minutes in any setting to run routine EEG studies.

Brain Scientific can potentially change the United States’ landscape and eliminate neurology deserts once and for all. It’s time everyone had access to the life-saving research available.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• Company announces flagship product name, logo now protected intellectual property rights
• “Securing our trade name is another step forward in the dawning of the Hourglass era,” says CEO
• Grapefruit intends to apply for similar trademark protection when the federal government legalizes cannabis

Grapefruit USA (OTCQB: GPFT), a fully licensed, California-based cannabis company, has secured California Trademark protection for its patented disruptive Hourglass(TM) THC/Cannabinoid time-release delivery cream. The trademark protection means that the Hourglass name and logo are now protected intellectual property rights of Grapefruit and no other cannabis companies can use them. “Obtaining our California Trademark protection for Hourglass is pivotal for us to protect our intellectual property rights and good will with respect to Grapefruit’s Hourglass line of products,” said Grapefruit CEO Bradley J. Yourist. “It is only fitting that Grapefruit has exclusive rights to the Hourglass name and logo since Grapefruit has an exclusive license for use of the patented technology upon which the Hourglass time release delivery cream is based and is the only enterprise on earth with the technical know-how to manufacture the Hourglass delivery cream for the regulated cannabis market. That symmetry is exquisite. Securing our trade name is another step forward in the dawning of the Hourglass era. Hourglass products may only be obtained from Grapefruit and its authorized agents.” In addition to precluding other companies from using the name, the trademark protection gives Grapefruit common law, first-in-time, trademark protection to Hourglass. The company intends to apply for similar trademark protection when the federal government legalizes cannabis, a move that many industry experts feel is imminent, perhaps even this year. “We previously secured California trademark and service mark protections for the Grapefruit corporate name and other product lines, Sugar Stoned and Rainbow Dreams,” Yourist continued. “Currently, the federal government does not allow cannabis companies to obtain federal trademark protection of its intellectual property. We, however, have long understood our operational environment and moved to protect our intellectual property rights at the state level because such state-level registration provides Grapefruit with a significant level of protection on a national basis via common law first-in-time use of our product names. We believe that protection of our intellectual property rights is important to enhance and protect Grapefruit’s value for its shareholders.” Hourglass products are manufactured exclusively at Grapefruit’s Coachillin facility by highly trained Grapefruit personnel and are available to the public only through Grapefruit authorized retailers. Grapefruit has packed the entire cannabis plant into its patented cream to provide users with a wide array of cannabinoids and THC to consistently deliver the desired synergistic entourage effects. To find out more about the company and its game-changing Hourglass time release THC+ Cannabinoid delivery cream, please visit www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

• Biden calls for 100-day review of strategic supply chains
• Already leading uranium/vanadium producer, UUUU has made significant strides in REE space in 2021
• Energy Fuels on schedule to produce intermediate rare earth product in 2021

In the midst of President Joe Biden’s 100-day review of U.S. strategic supply chains (https://ibn.fm/jc5jW), companies around the country, including Energy Fuels (NYSE American: UUUU) (TSX: EFR), are watching closely for the results. Last year, Energy Fuels, the country’s largest producer of uranium and the leading conventional producer of vanadium, announced plans to enter the rare earth elements (“REE”) space. Just under a year later, the company is about to begin commercial production of an intermediate rare earth product at its facility in Utah. This product contains excellent distributions of the rare earths needed for electric vehicles (“EVs”), renewable energy systems, batteries, technology, and military and defense applications. The supply chain review is intended to boost manufacturing jobs by strengthening U.S. supply chains for advanced batteries, pharmaceuticals, critical minerals and semiconductors; the review will also examine the nation’s reliance on imports of these goods — a potential national security and economic risk that the Biden administration hopes to address. “These are the kinds of common sense solutions that all Americans can get behind,” Biden said, discussing the review. “It’s about resilience, identifying possible points of vulnerabilities in our supply chains and making sure we have the backup alternatives or workarounds in place.” The review appeared to be distinctly bipartisan; an AP article reported that Biden met with Republican and Democratic lawmakers at the Oval Office before signing the order. “This is a critical area where Republicans and Democrats agreed — it was one of the best meetings I think we’ve had so far and we’ve only been here about five weeks,” Biden said. “It was like the old days. People were actually on the same page.” Energy Fuels has a keen interest in the outcome of the analysis. Last year, the company announced its interest in entering the REE market as a complement to its core uranium and recycling businesses. Since that announcement, the company has emerged as a major player in the commercial rare earth business. Its initial goal was to enter the commercial REE business in H1 2021, working to supply up to 50% of U.S. rare earth demand contained in a mixed REE carbonate over the next few years. The company is expected to soon begin processing its first monazite ore at its White Mesa Mill in Blanding, Utah, and producing a marketable mixed rare earth element carbonate. If successful Energy Fuels will be producing a rare earth product at a stage more advanced than any other U.S. company. This work represents a crucial step toward re-establishing a fully integrated U.S. rare earth element supply chain. In addition, the company has plans to install REE separation and additional downstream capabilities over the next few years. These plans can be implemented within the company’s existing infrastructure (https://ibn.fm/gSXQP). With its expansion into the growing REE market, strong balance sheet, diverse business opportunities, and all debt paid off last year, the company is leveraging a robust business model that allows it to be well positioned to capitalize on the increasing momentum for the REE space. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• Shark Tank survivor James Martin sells Copa Di Vino to SBEV, 13,000 new retail locations in acquisition agreement
• Copa Di Vino is ready-to-drink portable wine glass that doesn’t require bottle or corkscrew
• After Shark Tank appearance, Copa Di Vino generated tens of millions of dollars in revenue
• SBEV develops, accelerates, grows pre-existing brands for profitable exit events

After turning down multiple offers on Shark Tank years ago, James Martin, the show’s “most infamous entrepreneur” and founder of Copa Di Vino, ultimately sold his business to Splash Beverage Group (OTCQB: SBEV), a portfolio company of successful beverage brands (https://ibn.fm/CKk7L). SBEV management is confident it can accelerate the Copa Di Vino brand for massive expansion through its top-tier production, supply chain and global distribution capabilities. “The acquisition adds a remarkable revenue stream to Splash’s bottom line and includes Copa Di Vino’s proprietary packaging technology, an innovation suitable for a number of applications across the Company’s growing portfolio of beverage brands and industry solutions,” said SBEV CEO Robert Nistico. After turning down the sharks – not once, but twice – Copa Di Vino went on to generate tens of millions of dollars in revenue. Fueled by Martin’s passion for wine and technological expertise, the brand features innovative packaging that allows winemakers to ship their products in a single-serve format, allowing connoisseurs to consume and carry wine in a convenient, portable design. “That’s never been done with wine before, and I grant him that was a good move,” said Kevin O’Leary, renowned venture capitalist and star of Shark Tank. Packaged wine in sizes below 500ml are gaining rapid traction across the United States, according to IWSR Drinks Market Analysis (https://ibn.fm/5qxI8). Single-serve adult beverages like Copa Di Vino’s “wine in a glass” are growing in popularity for consumption at outdoor events due to their easy portability and non-breakable nature—especially in light of COVID-19’s accelerated impact on carry-out services and outdoor seating availability at eateries. SBEV’s acquisition of Copa Di Vino is leveraging this trend through new distribution channels that include the Anheuser-Busch Network, 13,000 retail locations across various chains, and new e-commerce outlets. “As the large venue segment reopens for sports, concerts and other live audience events, we expect to capture meaningful sales volume as this packaging is a perfect fit for stadiums, theaters and other large venues, and the patented packaging technology is not limited to wine,” said Nistico. “We anticipate making use of the versatile utility here in a very big way as market opportunities continue to emerge and resurface.” Among SBEV’s current portfolio are three other unique brands that include TapouT Performance – a natural isotonic hydration & recovery sports drink, Salt Naturally Flavored Tequila, and Pulpoloco Sangria – a premium crafted sangria in an eco-friendly biodegradable catocan. Led by an expert management team with a track record of success, SBEV’s strategy is to rapidly develop and accelerate pre-existing brands that can be profitably exited for cash events. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

• Every product features three parts: dosing device, formulation accessory and mobile app
• HIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment plan
• RYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment

RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments (https://ibn.fm/1wvz4). Every product features three parts: the device, the formulation accessory (QR labeled product) and the mobile application. These parts work together to control the dosing while also capturing important data that can lead to breakthroughs in plant-based medicine. Every RYAH dose-measuring product has an innovative dose-control solution. Using QR-labeled products, patients can track what they use and evaluate what dosing parameters work best for each product. The QR labeling allows for advanced session tracking and journaling and is designed to ensure safety. Patients can then control and rate the effectiveness of each session on RYAH’s mobile app. This allows the user to tweak future doses to provide more optimal results. The HIPPA-compliant cloud collects data along each step of the ecosystem that is essential in tailoring a personalized treatment plan moving forward. The suite of products also provides critical information for future treatment of patients with various medical conditions. The company releases a monthly in-depth analytical report sharing publicly identified trends and how dosing affects consumer outcomes. RYAH ecosystem includes a range of IoT devices, including Smart Patch, Smart Inhaler and the upcoming Smart Pen, as well as RYAH MD remote health platform. The Smart Patch allows users to access on-demand relief and schedule doses based on when their symptoms are the most severe. After using the QR labeled product, the mobile app’s user records how well the patch worked. Users can then review stats and create an optimized schedule for later use. It creates an organized record of what patches worked best. RYAH’s Smart Inhaler allows users to control how much is inhaled, ensuring consistent and predictable results. Temperature and dosage can be controlled, and then the effects can be recorded in the mobile app. Statistics can be reviewed, and dosing can be altered accordingly for future uses. The Smart Pen allows for oral consumption and can uniquely dose up to three different liquid formulations for a highly personalized effect. The dose can be added to a drink or directly into the mouth. The app is then used to record the effects of the dose for review to make any changes for future dosing. RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with the before-mentioned dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on the smart devices for dosing, review the information in real-time, and make changes remotely to the doses delivered. It will enable doctors to monitor their patients and ensure that they are following the recommended procedures. RYAH Cloud captures all of the structured and unstructured data from the dosing products and the mobile apps and analyzes the information. This allows doctors and clinics to develop more personalized therapies that can reshape our medical future. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH